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Interactions between host cells and foamy or spumaretroviruses are different from those of other known retroviruses.
Previous work has suggested that the Gag and high-affinity DNA-binding Bel 1 transactivator of human foamy virus are
localized in the nuclei of infected cells. Using two independent detection methods, we show here that the functionally active
Bel 1 transactivator protein of feline foamy virus is of nuclear localization. In contrast to that reported for the human foamy
virus Gag protein, the cat foamy virus Gag proteins exclusively localized in the cytoplasm close to perinuclear regions.
© 1998 Academic Press
INTRODUCTION
Spumaviruses, or foamy viruses (FVs), belonging to
the retroviruses encode not only the structural proteins
Gag, Pol, and Env but also a strong transcriptional trans-
activator Bel 1 (Tas) that is required for virus replication
and that directly binds to DNA target sequences (He et
al., 1996; Kang et al., 1998; Zou and Luciw, 1996). Char-
acteristic features of FVs not shared by other complex
retroviruses include the presence of a potent internal
promoter besides the 59 long terminal repeat (LTR) pro-
moter (Bodem et al., 1998; Lo¨chelt et al., 1993; Mergia,
1994). In addition, the FV pol genes are expressed from
a spliced pol transcript (Bodem et al., 1996; Yu et al.,
1996a).
Recently the nuclear import and export pathways for
various proteins and RNAs were studied extensively
(Go¨rlich and Mattaj, 1996; Nigg, 1996). The functional
properties and cellular localizations of retroviral proteins
such as HIV-1 Tat and Rev have been analyzed in detail
(Cullen and Malim, 1991), and unique nuclear structures
have been reported for the HTLV-I Tax transactivator (Bex
et al., 1997), The subcellular localizations of spumaretro-
viral proteins have not been extensively characterized
(Lo¨chelt and Flu¨gel, 1995; Mergia and Luciw, 1991; Re-
thwilm, 1995).
The feline FV (FeFV) transactivator Bel 1 and Gag
proteins are shorter in length than the corresponding
human FV (HFV) proteins. Surprisingly, both reveal little,
if any, homology on the protein sequence level compared
with the corresponding gene products of primate FVs
and HFV. The FeFV Bel 1 is expressed exclusively from
the internal promoter (Bodem et al., 1998), which is in
contrast to that of HFV, for which bel 1 transcripts were
observed that started at the 59 LTR promoter (Lo¨chelt and
Flu¨gel, 1995). The FeFV Bel 1 does not contain the clas-
sic basic nuclear localization signal (NLS) but likely con-
tains an unusual bipartite signal motif (Winkler et al.,
1997). The HFV Bel 1 has been reported to contain a
functional NLS that contains the conserved classic motif
(Chang et al., 1995).
The FeFV Gag lacks the Arg-Gly-rich motifs character-
istic of the primate FV Gag COOH-terminal domains
(Winkler et al., 1997). The HFV Arg-Gly-rich boxes were
reported to be responsible for nuclear localization by
genetic analysis (Schliephake and Rethwilm, 1994). How-
ever, a more recent report clarified that this subcellular
localization was not required for infectivity (Yu et al.,
1996b).
Through the use of different methods and cell types,
the study goal was to determine where the Bel 1 and Gag
proteins of FeFV are localized.
RESULTS AND DISCUSSION
Localization of the Bel 1 transactivator protein
To determine the subcellular localization of the FeFV
Bel 1 transactivator protein, cloning was carried out that
resulted in the expression of a GFP-Bel 1 fusion protein.
The plasmid contained gfp 59 of the bel 1 gene. The
variant GFP used had been adapted for mammalian cells
with a optimal fluorescence shifted into the red and an
activity that is 35 times higher than that of wild-type GFP
(Zolotukhin et al., 1996). The expression plasmid pBK-
CMV-gfpbel1 was transfected into either HeLa or Cran-
dell feline kidney (CRFK) cells. Two days after transfec-
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tion, the localization was analyzed with fluorescence
microscopy (Fig. 1). No fixation was necessary; thus the
resulting image was not affected by different fixation
techniques. Examination of the transfected HeLa cells
(Figs. 1A and 1B) clearly revealed nuclear localization of
the GFP-Bel 1 protein. The same result was obtained
when CRFK cells were examined with UV light (Figs. 1C
and 1D). To determine whether the recombinant GFP-Bel
1 protein was still biologically active and whether the
transactivator activity was comparable with that of wild-
type Bel 1, transient expression assays were performed
with a cotransfected 59 LTR-based luciferase plasmid.
The data obtained showed that the Bel 1 protein was
active and functioned as transcriptional transactivator
(Table 1). This subcellular localization was confirmed
through direct microinjections of recombinant MBP-Bel 1
protein (data not shown). This result is in agreement with
the known capability of Bel 1 to bind DNA with high
affinity and of serving as transactivator for transcription.
It is unknown what mechanisms are responsible for
exporting spumaviral transcripts from the nuclei into the
cytoplasm of infected cells. To examine whether Bel 1 is
capable of shuttling between the cytoplasm and cell
nuclei, thereby exporting cargo, an MBP-bel 1 recombi-
nant plasmid was constructed, and Bel 1 was expressed
as MBP-Bel 1 fusion protein. The MBP-Bel 1 protein was
labeled with FLUOS and microinjected into one of sev-
eral polynucleated nuclei of HeLa cells grown onto cov-
erslips. After incubation for 30 min, the cells were fixed
and examined with fluorescence microscopy. The result
shown in Fig. 2 clearly identified Bel 1 as nuclear protein
that remained in the nuclei of transfected cells, indicat-
ing that FeFV Bel 1 does not shuttle between the cyto-
plasm and the nucleus under the conditions used. As
control, MBP-Bel 1 protein was microinjected into the
cytoplasm of HeLa cells. It was observed that the fusion
protein was transported into the nucleus but did not
shuttle between the two cellular compartments. Inspec-
tion of the FeFV Bel 1 sequence showed that a con-
served basic NLS motif is not present, which is in con-
trast to those of the primate FV Bel 1 (Chang et al., 1995).
We assume that FeFV Bel 1 contains an unorthodox
nonconserved NLS motif, as suggested previously (Win-
kler et al., 1997).
Subcellular localization of the GFP-Gag fusion protein
To determine the subcellular localization of the FeFV
Gag structural protein, an approach was chosen analo-
gous to that described above for the Bel 1 protein. To
determine the subcellular localization of the viral protein
Gag, cloning was carried out that resulted in the expres-
sion of a Gag-GFP fusion protein. Again, the gfp gene
was cloned upstream of the viral gag gene. Plasmid
DNAs (pBK-CMV-gfpgag; for details, see Materials and
Methods) from two independently prepared gfp-gag
clones were separately transfected into BHK, CRFK, and
COS cells. Examination by UV light microscopy 2 days
after transfection showed that the GFP-Gag protein ex-
clusively localized in the cytoplasm in distinct structures
close to perinuclear regions. (Figs. 3A–3C). Neither a
nuclear localization nor a random cellular distribution of
GFP-Gag was found. The narrow point-like clustering of
the GFP-Gag fluorescent protein on the outside of nuclei
indicates that these regions presumably represent cyto-
plasmic preassembly sites of FeFV capsids and might be
explained by the presence of a morphogenetic signal
motif identified by Rhee and Hunter (1990) in type D
retroviruses. A closely related signal sequence motif
also occurs in the matrix domain of FeFV Gag at a
genetically similar position as in that of Mason–Pfizer
monkey virus (Winkler et al., 1997). In addition, distinct
morphological features adjacent to the nucleus that are
reminiscent of those found here were also reported for
HFV Gag (Saib et al., 1997).
Additional immunofluorescence experiments with an-
tiserum directed against the matrix domain of FeFV Gag
revealed that in CRFK cells, Gag concentrated in perinu-
clear regions (Fig. 4A). Again, nuclei of infected CRFK
cells were not stained with a matrix domain-specific
antiserum but rather were stained with DAPI (Fig. 4B).
Taken together, our data show FeFV does not localize to
the cell nuclei of infected or transfected cells; instead, it
localized in perinuclear regions of both BHK and CRFK
cells. This might be due to the sequence differences
present in the COOH-terminal (NC like) regions of FeFV
Gag (Winkler et al., 1997), although alternative explana-
tions cannot be ruled out.
MATERIALS AND METHODS
Expression cloning
Two primers were used to amplify gfp (green fluores-
cent protein) from plasmid vector pTR-UF5 (Zolotukhin et
al., 1996) with Pfu DNA polymerase and cloned into the
pBK-CMV plasmid that had been modified by adding PstI
and SpeI sites (Stratagene, Heidelberg, Germany). The
FeFV gag gene was amplified with Pfu DNA polymerase
and two primers (59-GGACTAGTATGGCTCGAGAATTAA-
FIG. 1. Distribution of the FeFV GFP-Bel 1 fusion protein. pBK-CMV-gfpbel1 plasmid DNA (20 mg) was transfected into HeLa cells and visualized
2 days after transfection with fluorescence microscopy (A) and phase contrast (B). (C and D) Analogous experiments with CRFK cells 3 and 4 days
after transfection.
FIG. 2. Microinjection of MBP-Bel 1 fusion protein (3 mg/ml) labeled with either rhodamine-labeled IgG (A) or FLUOS (B) into a HeLa cell nucleus.
After incubation for 30 min, photographs were taken under UV light (B) and by phase contrast (C).
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ATCCTCTCC-39 and 59-GGATCGATAACCTTTAATCTTTA-
CCCCCTTTCTTTCC-39), cut with SpeI, and ligated into
the vector pBK-CMV-GFP predigested with SpeI plus
SmaI (rapid ligation kit; Boehringer-Mannheim, Mann-
heim, Germany). FeFV gag was cloned directly down-
stream of the gfp gene of the pBK-CMV-gfp plasmid into
the same reading frame. Restriction enzyme analysis
confirmed the correct orientation and size of the inserts.
On expression and subsequent gel electrophoresis un-
der denaturing conditions, a polypeptide of the expected
molecular size for the GFP-Gag fusion protein was de-
tectable. To obtain antiserum against the MA domain of
FeFV Gag, polymerase chain reaction (PCR) products of
FeFV DNA from coordinates 1205s and 2171a as primers
were used and cloned into pET16b (Winkler et al., 1997).
Bacterially expressed recombinant proteins were puri-
fied and used to immunize rabbits.
The plasmid pBK-CMV-gfp-bel1 was constructed by
using PCR-amplified bel 1 sequences with primers that
contained a SpeI site at the 59 end and a ClaI site at the
39 end. The sense primer had the authentic ATG codon
directly downstream of the SpeI site; the antisense
primer had the authentic bel 1 stop codon. The resulting
recombinant plasmid was ligated into plasmid pBK-CMV-
gfp that had been digested with SpeI and SmaI. Restric-
tion enzyme analysis and in vitro translation was used to
verify the correct size and orientation of the inserts.
Construction of the maltose binding protein-bel1
plasmid (MBP-bel1)
Bel 1 sequences were obtained through PCR with the
sense primer bgl-bel1s 59-CCACTAGTATGGCTCAAAATA-
CCCGGAAGAAGG-39 from the 39 LTR plasmid (Bodem et
al., 1996) and the antisense primer Fbela 59-GCCATCG-
ATTTGTACCAGGCCTATTCCTGG-39 (Winkler et al., 1997)
with Pfu DNA polymerase. The plasmid pMalbel1 was
cut by BamHI and SalI and blunt-end ligated into the
pMal-c2 vector (New England Biolabs) digested with
BglII. Escherichia coli DH5a cells (GIBCO, Karlsruhe,
Germany) were transformed according to standard pro-
cedures. The vector-insert borders of all plasmids were
confirmed by nucleotide sequencing.
Cell culture, transfection, and transient expression
assays
BHK, CRFK, and HeLa cells were grown as described
previously (Bodem et al., 1996). Transfections were done
according to Winkler et al. (1997). Luciferase assays
were carried out with the pFeFV-LTR plasmid as reporter
for the determination of transactivation activities of the
different bel 1-containing constructs under conditions
described previously (Winkler et al., 1997; Zolotukhin et
al., 1996).
Immunofluorescence
MBP-Bel 1 fusion protein was labeled with the fluores-
cein derivative FLUOS (Boehringer) as described previ-
ously (Truant et al., 1998). The cellular localization of the
injected protein was determined by fluorescence at a
magnification of 1003. The rhodamine-conjugated goat
anti-mouse IgG antibody was used (Cappel). Photo-
graphs were taken after FITC staining at 495 nm and
after staining with DAPI (Sigma) at 365 nm.
Shuttle assay and microinjections
The assays for probing shuttling of the Bel 1 between
cytoplasm and nucleus were carried out as described
recently (Fridell et al., 1997). Briefly, HeLa cells were
seeded onto coverslips and grown in serum-free me-
dium for 12 h. During this period, ;20% of the cells
contained polynuclei. Labeled MBP-Bel1 protein was mi-
croinjected into one nucleus of the cells that contained
polynuclei. After 30 min at 37°C, the microinjected HeLa
cells were examined under UV light.
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TABLE 1
Transactivation of FeFV LTR Promoter-Based Luciferase Reporter








pGL2-basic 9 23 27 2.5–3
pFeFV-LTR 25 214, 148 202, 871 8355
a Data are expressed as relative luciferase units normalized to co-
transfected b-Gal activity.
FIG. 3. Distribution and fluorescence of the GFP-FeFV Gag protein in BHK cells. (A) Plasmid gfp-gag (20 mg of DNA) was transfected into BHK cells
and examined by phase contrast and UV light 2 days after transfection at 2003 magnification. Arrow indicates GFP-Gag localized in the cytoplasm
close to perinuclear regions (B) Photograph taken 4 days after transfection at 4003 magnification. (C) Same as in B but in UV light only.
FIG. 4. (A) Distribution and fluorescence of the FeFV Gag protein in FeFV-infected CRFK cells fixed with paraformaldehyde 3 days p.i. Cells reacted
with rabbit antiserum raised against the MA domain of FeFV Gag at 1:200 dilution. (B) Nuclear staining of the same area with DAPI showing syncytial
CPE.
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